References
- Catlin BW. Transfer of the organism named Neisseria catarrhalis to Branhamella. Int J Syst Bacteriol 1970: 20: 155–9
- Doern GV. Branhamella catarrhalis—an emerging human pathogen. Diag Microbiol Infect Dis 1986: 4(3): 191–201
- Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J 1978: 1 (6108): 276–8
- McLeod DT, Ahmad F, Power JT, et al. Bronchopulmonary infection due to Branhamella catarrhalis. Br Med J (Clin Res) 1983: 287(6403): 1446–7
- Slevin NJ, Aitken J, Thornley PE. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet 1984: 1(8380): 782–3
- Nicotra B, Rivera M, Luman JI, et al. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986: 146(5): 890–3
- McLeod DT, Ahmad F, Capewell S, et al. Increase in bronchopulmonary infection due to Branhamella catarrhalis. Br Med J (Clin Res) 1986: 292(6528): 1103–5
- Louie MH, Gabay EL, Mathisen GE, et al. Branhamella catarrhalis pneumonia. West J Med 1983: 138(1): 47–9
- Chapman AJ Jr, Masher DM, Jonsson S, et al. Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis 1985: 151(5): 878–82
- Wald ER, Milmoe GJ, Bowen A, et al. Acute maxillary sinusitis in children. N Engl J Med 1981: 304(13): 749–54
- Kamme C, Lundgren K, Mårdh PA. The aetiology of acute otitis media in children. Occurrence of bacteria, L forms of bacteria and mycoplasma in the middle ear exudate: relationship between bacterial findings in the middle ear exudate, nasopharynx and throat. Scand J Infect Dis 1971: 3(3): 217–23
- Schalen L, Christensen P, Kamme C, et al. High Isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis 1980: 12(4): 277–80
- Brorson JE, Malmvall BE. Branhamella catarrhalis and other bacteria in the nasopharynx of children with longstanding cough. Scand J Infect Dis 1981: 13(2): 111–3
- Doern GV, Morse SA. Branhamella (Neisseria) catarrhalis: criteria for laboratory Identification. J Clin Microbiol 1980: 11(2): 193–5
- Sweeney KG, Verghese A, Needham CA. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother 1985: 27(4): 499–502
- Alvarez S, Jones M, Holtsclaw-Berk S, et al. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother 1985: 27(4): 646–7
- Buu Hoi-Dang Van A, et al. Novel beta-lactamase from Branhamella catarrhalis. Ann Microbiol (Institute Pasteur) 1978: 129B: 397–406
- McNeely DJ, Kitchens CS, Kluge RM. Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host. Am Rev Respir Dis 1976: 114(2): 399–402
- Srinivasan G, Raff MJ, Templeton WC. et al. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. Am Rev Respir Dis 1981: 123(5): 553–5
- Patterson TF, Patterson JE, Masecar BL, et al. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988: 157(5): 996–1001
- Wollschlager CM, Raoof S, Khan FA, et al. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. Am J Med 1987: 82(4A): 164–8
- Bauernfeind A. Antimicrobial activity of ciprofloxacin: an overview. In: Neu HC, Wenta H, eds. Proceedings of the 1st International Ciprofloxacin Workshop. New York: Elsevier Science Publishing (Excerpta Medica), 1986: 7–11